Ligand-dependent switching of ubiquitin–proteasome pathways for estrogen receptor
Open Access
- 11 November 2004
- journal article
- research article
- Published by Springer Nature in The EMBO Journal
- Vol. 23 (24) , 4813-4823
- https://doi.org/10.1038/sj.emboj.7600472
Abstract
Recent evidence indicates that the transactivation of estrogen receptor α (ERα) requires estrogen‐dependent receptor ubiquitination and degradation. Here we show that estrogen‐unbound (unliganded) ERα is also ubiquitinated and degraded through a ubiquitin–proteasome pathway. To investigate this ubiquitin–proteasome pathway, we purified the ubiquitin ligase complex for unliganded ERα and identified a protein complex containing the carboxyl terminus of Hsc70‐interacting protein (CHIP). CHIP preferentially bound to misfolded ERα and ubiquitinated it to induce degradation. Ligand binding to the receptor induced the dissociation of CHIP from ERα. In CHIP−/− cells, the degradation of unliganded ERα was abrogated; however, estrogen‐induced degradation was observed to the same extent as in CHIP+/+ cells. Our findings suggest that ERα is regulated by two independent ubiquitin–proteasome pathways, which are switched by ligand binding to ERα. One pathway is necessary for the transactivation of the receptor and the other is involved in the quality control of the receptor.Keywords
This publication has 42 references indexed in Scilit:
- Protein degradation and protection against misfolded or damaged proteinsNature, 2003
- Estrogen Receptor-α Directs Ordered, Cyclical, and Combinatorial Recruitment of Cofactors on a Natural Target PromoterCell, 2003
- Cyclic, Proteasome-Mediated Turnover of Unliganded and Liganded ERα on Responsive Promoters Is an Integral Feature of Estrogen SignalingPublished by Elsevier ,2003
- Peroxisome Proliferator-activated Receptor α (PPARα) Turnover by the Ubiquitin-Proteasome System Controls the Ligand-induced Expression Level of Its Target GenesJournal of Biological Chemistry, 2002
- Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated TranscriptionCell, 2000
- Structure of TPR Domain–Peptide ComplexesCell, 2000
- Posttranslational Quality Control: Folding, Refolding, and Degrading ProteinsScience, 1999
- 1,25-Dihydroxyvitamin D3 Increases Nuclear Vitamin D3 Receptors by Blocking Ubiquitin/Proteasome-Mediated Degradation in Human SkinMolecular Endocrinology, 1999
- A transcriptionally active estrogen receptor mutant is a novel type of dominant negative inhibitor of estrogen actionMolecular Endocrinology, 1996
- Repression of endogenous estrogen receptor activity in MCF-7 human breast cancer cells by dominant negative estrogen receptorsEndocrinology, 1995